Search

everythinglearnresearchcommunity

for

Search:↓

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Azathioprine can help with relapses and disability in NMOSD but has more side effects and needs more research.

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

A comprehensive approach to educating patients and managing side effects is crucial for improving adherence to multiple sclerosis treatments and patient quality of life.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Frontal fibrosing alopecia is linked to increased immune system activity and reduced stem cells, suggesting early treatment targeting this pathway might prevent hair follicle damage.

Stress in hair follicle stem cells causes inflammation in a chronic skin condition through a specific immune response pathway.

COVID-19 infection may trigger alopecia areata in some patients.

JAK inhibitors helped treat hair loss in two people with Down syndrome.

Hepatitis C virus can cause skin diseases and dermatologists play a crucial role in identifying these conditions.

Intralesional therapy for keratoacanthoma is effective and has fewer side effects than systemic treatments.

Zinc supplementation may help improve treatment outcomes for chronic hepatitis C.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

Mesenchymal stem cells in people with Hidradenitis Suppurativa are more inflammatory, possibly contributing to the disease.

Hepatitis B virus exposure may be linked to increased risk of alopecia areata.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

Different treatments for alopecia areata have unpredictable results and varying success rates.

JAK inhibitors show promise for treating hair loss in alopecia areata but need more clinical trials to confirm safety and effectiveness.

Ruxolitinib may help treat hair loss by reducing inflammation, promoting hair growth signals, and protecting hair follicle immunity.

Mesenchymal stem cell therapy may help treat alopecia areata by promoting hair growth and reducing inflammation.

Dengue virus can infect human hair follicle cells and may cause hair loss.

Mesenchymal stem cells may help treat hair loss by improving hair cell growth and reducing inflammation.

CO2 laser treatment for aging skin significantly changes immune system-related genes.

Hair follicle stem cells reduced hair loss and inflammation in mice with a condition similar to human alopecia.

Mycophenolate helps reverse hair loss effects caused by IFN-γ by activating a key hair growth pathway.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.